Xtant Medical

51 articles about Xtant Medical

• Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million

  4/1/2024

  Xtant Medical Holdings, Inc. reported financial and operating results for the fourth quarter and year ended December 31, 2023.

• Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial

  3/7/2024

  Xtant Medical Holdings, Inc. announced that the Company’s revolving credit agreement with MidCap Financial Trust was amended to increase the commitment from $8.0 million to $17.0 million.

• Xtant Medical to Participate in Upcoming Investor Conferences

  2/5/2024

  Xtant Medical Holdings, Inc. today announced that management will participate in two upcoming investor conferences.

• Xtant Medical to Participate in Upcoming November 2023 Investor Conferences

  11/9/2023

  Xtant Medical Holdings, Inc., a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that management will participate in two upcoming investor conferences.

• Xtant Medical Announces Record Third Quarter Revenue of $25 Million

  11/9/2023

  Xtant Medical Holdings, Inc., a global medical technology company focused on surgical solutions for the treatment of spinal disorders, reported financial and operating results for the third quarter ended September 30, 2023.

• Xtant Medical Announces Acquisition of nanOss Production Operations from RTI Surgical

  10/23/2023

  Xtant Medical Holdings, Inc. announced that it has acquired the nanOss production operations from RTI Surgical, Inc., a leading CDMO in regenerative medicine.

• Xtant Medical Highlights Growing Product Portfolio at NASS 2023

  10/12/2023

  Xtant Medical Holdings, Inc. announced it will exhibit its suite of orthobiologics and spinal fixation products at the North American Spine Society 2023 Annual Meeting, which will be held October 18-21 at the Los Angeles Convention Center in Los Angeles, CA.

• Xtant Medical Completes Acquisition of Surgalign’s Hardware and Biologics Business

  8/10/2023

  Xtant Medical Holdings, Inc. announced that it completed the acquisition of certain assets and liabilities related to the domestic and international biologics and spinal fixation offerings of Surgalign Holdings, Inc. under a Bankruptcy Court supervised process for $5 million, plus assumed liabilities, in an all-cash transaction.

• Xtant Medical Announces Second Quarter 2023 Revenue Growth of 32%

  8/1/2023

  Xtant Medical Holdings, Inc., a global medical technology company focused on surgical solutions for the treatment of spinal disorders, reported financial and operating results for the second quarter ended June 30, 2023.

• Xtant Medical Wins Auction for Surgalign’s Hardware and Biologics Business

  7/28/2023

  Xtant Medical Holdings, Inc. announced that it was the successful bidder for certain assets and liabilities related to the domestic and international biologics and spinal fixation offerings of Surgalign Holdings, Inc.

• Xtant Medical Announces Closing of $15 Million Private Placement

  7/7/2023

  Xtant Medical Holdings, Inc. today announced the closing of its previously announced $15 million private placement with accredited investors.

• Xtant Medical Announces $15 Million Private Placement

  7/3/2023

  Xtant Medical Holdings, Inc. today announced it has entered into a securities purchase agreement with accredited investors to sell shares of its common stock in a private placement.

• Xtant Medical Appoints Lori Mitchell-Keller to Board of Directors

  5/18/2023

  Xtant Medical Holdings, Inc. today announced the appointment of Lori Mitchell-Keller to the Company's Board of Directors effective May 16, 2023.

• Xtant Medical Announces First Quarter 2023 Revenue Growth of 38% and Full Year 2023 Revenue Guidance

  5/4/2023

  Xtant Medical Holdings, Inc. today reported financial and operating results for the first quarter ended March 31, 2023.

• Xtant Medical to Issue First Quarter 2023 Financial Results on May 4, 2023

  4/27/2023

  Xtant Medical Holdings, Inc. today announced that it will release its financial results for the first quarter ended March 31, 2023, before the open of the financial markets on Thursday, May 4, 2023.

• Xtant Medical to Issue Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

  3/3/2023

  Xtant Medical Holdings, Inc. announced that it will release its financial results for the fourth quarter and full year ended December 31, 2022, before the open of the financial markets on Tuesday, March 7, 2023.

• Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million

  3/1/2023

  Xtant Medical Holdings, Inc. and Surgalign Holdings, Inc. announced the completion of a transaction between the companies.

• Xtant Medical Appoints Mark Schallenberger as Chief Operations Officer

  1/9/2023

  Xtant Medical Holdings, Inc. today announced the appointment of Mark Schallenberger as Chief Operations Officer, effective January 16, 2023.

• Xtant Medical Announces Third Quarter 2022 Financial Results

  11/3/2022

  Xtant Medical Holdings, Inc. reported financial and operating results for the third quarter ended September 30, 2022.

• Xtant Medical to Issue Third Quarter 2022 Financial Results on November 3, 2022

  10/27/2022

  Xtant Medical Holdings, Inc. announced that it will release its financial results for the third quarter ended September 30, 2022, before the open of the financial markets on Thursday, November 3, 2022.